156 related articles for article (PubMed ID: 37818684)
1. Nanotechnology-based cancer chemoprevention in glioblastoma.
Adylova A; Kapanova G; Datkhayeva Z; Raganina K; Tanbayeva G; Baigonova K
Folia Neuropathol; 2023; 61(3):235-241. PubMed ID: 37818684
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
Banstola A; Duwa R; Emami F; Jeong JH; Yook S
Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
[TBL] [Abstract][Full Text] [Related]
3. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
[TBL] [Abstract][Full Text] [Related]
4. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
Pellosi DS; Paula LB; de Melo MT; Tedesco AC
Mol Pharm; 2019 Mar; 16(3):1009-1024. PubMed ID: 30698450
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
Rezaei V; Rabiee A; Khademi F
J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
8. The Role of Nanotechnologies in Brain Tumors.
Caffo M; Caruso G; Curcio A; Laera R; Crisafulli C; Fazzari E; Passalacqua M; Germanò A
Adv Exp Med Biol; 2023; 1394():181-192. PubMed ID: 36587388
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
Porru M; Zappavigna S; Salzano G; Luce A; Stoppacciaro A; Balestrieri ML; Artuso S; Lusa S; De Rosa G; Leonetti C; Caraglia M
Oncotarget; 2014 Nov; 5(21):10446-59. PubMed ID: 25431953
[TBL] [Abstract][Full Text] [Related]
10. Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma.
Janjua TI; Cao Y; Ahmed-Cox A; Raza A; Moniruzzaman M; Akhter DT; Fletcher NL; Kavallaris M; Thurecht KJ; Popat A
J Control Release; 2023 May; 357():161-174. PubMed ID: 36965857
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
12. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC
Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532
[TBL] [Abstract][Full Text] [Related]
14. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
[TBL] [Abstract][Full Text] [Related]
15. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
[TBL] [Abstract][Full Text] [Related]
16. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
18. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting.
Chu L; Wang A; Ni L; Yan X; Song Y; Zhao M; Sun K; Mu H; Liu S; Wu Z; Zhang C
Drug Deliv; 2018 Nov; 25(1):1634-1641. PubMed ID: 30176744
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications.
Ortiz R; Perazzoli G; Cabeza L; Jiménez-Luna C; Luque R; Prados J; Melguizo C
Curr Neuropharmacol; 2021; 19(4):513-537. PubMed ID: 32589560
[TBL] [Abstract][Full Text] [Related]
20. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
